CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
about
Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical woundsNew Is Old, and Old Is New: Recent Advances in Antibiotic-Based, Antibiotic-Free and Ethnomedical Treatments against Methicillin-Resistant Staphylococcus aureus Wound InfectionsCeftaroline fosamil: a brief clinical review.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections.Early response to antibiotic treatment in European patients hospitalized with complicated skin and soft tissue infections: analysis of the REACH study.Ceftaroline in the management of complicated skin and soft tissue infections and community acquired pneumonia.Treatment outcome measures for randomized controlled trials of antibiotic treatment for acute bacterial skin and skin structure infections in the emergency department settingSystematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection.Early endpoints for acute bacterial skin and skin structure infections.Early Response in Cellulitis: A Prospective Study of Dynamics and Predictors.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Avoiding the perfect storm: the biologic and clinical case for reevaluating the 7-day expectation for methicillin-resistant Staphylococcus aureus bacteremia before switching therapy.The times they are a-changin': new antibacterials for skin and skin structure infections.A critical review on the clinical pharmacokinetics, pharmacodynamics, and clinical trials of ceftaroline.Predictive score of haematological toxicity in patients treated with linezolid.Early response of ceftaroline fosamic in the treatment of soft-tissue infections.Efficacy and Safety of Oritavancin Relative to Vancomycin for Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI) in the Outpatient Setting: Results From the SOLO Clinical Trials.Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline.Robotic prostatectomy leading to a delayed MRSA infected lymphocele: a case report and review of the literature.Improving the fate of severely infected patients: the promise of anti-toxin treatments and superiority trials.
P2860
Q24202424-446A3815-FBDF-48A3-8654-6B865360026EQ26749376-9C7F7DC1-A8DD-49D7-83AB-B626A2AA6131Q33939080-EC696B05-A1B7-492C-A280-CC1A095E187AQ34478074-96922B26-71E0-44D4-8E51-C1DEF1C092D4Q34922533-2FD58F62-4538-48F8-BCC6-55495FFACF1AQ35155399-EBCA6D7D-33AE-468F-987C-9956B1574BB8Q35408518-18B11254-6024-4F97-B374-B861E4D02A0BQ35656230-6A94996C-C232-4B3D-BA8F-D8AFE5EC4C9FQ35860102-CCFE1B51-69B6-4DB4-9EF2-9AAB20EDA874Q35941449-2D0502E4-90F0-42F3-AD03-4DC88385915EQ37284156-B12A8932-D236-4796-A78B-35B0F53CB5D2Q38025132-5A2CA9DC-697D-481F-9568-7831A44A616AQ38117077-DF61A075-3570-4500-8253-06A7CBB9641DQ38185097-419682EE-54A6-40A6-90C1-AD73906A56A9Q38232494-572104C9-BD43-4A86-895F-AAF8F1FA0F71Q38438503-41B093DB-9C72-44DE-8EA6-BF211A84CA3FQ38458802-D01481CD-4837-4B1E-A405-EBE083D1C751Q38876028-5D8AB18E-0BB9-4C45-A620-0427D16A74B3Q39526506-6C83124B-010A-4B59-9FDE-509618D390C2Q40058085-3B101D01-8344-44E7-AD08-EEBFC265349CQ41123210-1F8B7C23-1B62-4766-A5D1-2EC750F73241Q49444902-E074C913-CF05-4C6E-84A1-CCB368E61329Q54323383-F402A49F-0E05-44FE-BB65-B46CD198D01C
P2860
CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@ast
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@en
type
label
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@ast
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@en
prefLabel
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@ast
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@en
P2093
P2860
P356
P1476
CANVAS 1 and 2: analysis of cl ...... and skin structure infections.
@en
P2093
Alex Smith
Donald Biek
Douglas R Rank
Gary W Witherell
H David Friedland
Joseph B Laudano
Lily Llorens
Paul B Eckburg
Tanya O'Neal
P2860
P304
P356
10.1128/AAC.05738-11
P407
P577
2012-02-06T00:00:00Z